{
  "id": 7302421,
  "title": "Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development",
  "url": "https://urgent.news/2026/09/14/psyence-biomed-establishes-texas-ibogaine-research-corporation-to",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-14T11:07:06.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/psyence-biomed-establishes-texas-ibogaine-research-corporation-to-advance-u-s-ibogaine-development"
  },
  "original_language": "en",
  "account": null,
  "summary": "Texas-based company is designed to coordinate U.S. development, pharmaceutical-grade supply and potential clinical sponsorship activities through a dedicated Psyence BioMed entity HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine development Positioned to hold U.S. rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to completion of definitive…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}